Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and …

MU Rehman, N Sehar, NJ Dar, A Khan, A Arafah… - Neuroscience & …, 2023 - Elsevier
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …

Mitochondrial dysfunction in Parkinson's disease–a key disease hallmark with therapeutic potential

MT Henrich, WH Oertel, DJ Surmeier… - Molecular …, 2023 - Springer
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic
Parkinson's disease (PD). However, strategies aimed at ameliorating mitochondrial …

Parkinson's disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella

H Lian, D Park, M Chen, F Schueder… - Nature …, 2023 - nature.com
Cell-intrinsic defences constitute the first line of defence against intracellular pathogens. The
guanosine triphosphatase RAB32 orchestrates one such defence response against the …

Trichloroethylene: An invisible cause of Parkinson's disease?

ER Dorsey, M Zafar, SE Lettenberger… - Journal of …, 2023 - journals.sagepub.com
The etiologies of Parkinson's disease (PD) remain unclear. Some, such as certain genetic
mutations and head trauma, are widely known or easily identified. However, these causes or …

Leucine-Rich Repeat Kinases

DR Alessi, SR Pfeffer - Annual Review of Biochemistry, 2024 - annualreviews.org
Activating mutations in leucine-rich repeat kinase 2 (LRRK2) represent the most common
cause of monogenic Parkinson's disease. LRRK2 is a large multidomain protein kinase that …

Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives

J Hu, D Zhang, K Tian, C Ren, H Li, C Lin… - European Journal of …, 2023 - Elsevier
Leucine-rich repeat kinase 2 (LRRK2) is a multifunctional protein that orchestrates a diverse
array of cellular processes, including vesicle transport, autophagy, lysosome degradation …

LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition

N Yadavalli, SM Ferguson - Proceedings of the National …, 2023 - National Acad Sciences
Cells maintain optimal levels of lysosome degradative activity to protect against pathogens,
clear waste, and generate nutrients. Here, we show that LRRK2, a protein that is tightly …

The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction

E Pajarillo, S Kim, A Digman, M Dutton, DS Son… - Journal of Biological …, 2023 - ASBMB
Chronic manganese (Mn) exposure can lead to manganism, a neurological disorder sharing
common symptoms with Parkinson's disease (PD). Studies have shown that Mn can …

[HTML][HTML] Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK/SOD2 pathway

Z Xie, M Zhang, Y Luo, D Jin, X Guo, W Yang… - Aging and …, 2023 - ncbi.nlm.nih.gov
Increasing evidence has shown that gut dysbacteriosis may play a crucial role in
neuroinflammation in Parkinson's disease (PD). However, the specific mechanisms that link …

The body, the brain, the environment, and Parkinson's disease

ER Dorsey, BR De Miranda… - Journal of …, 2024 - journals.sagepub.com
The brain-and body-first models of Lewy body disorders predict that aggregated alpha-
synuclein pathology usually begins in either the olfactory system or the enteric nervous …